Polymerase Chain Reaction Molecular Diagnostics Market Report 2026

Polymerase Chain Reaction Molecular Diagnostics Market Overview

• Polymerase Chain Reaction Molecular Diagnostics market size has reached to $9.75 billion in 2025 • Expected to grow to $14.65 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: Rising Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Increasing Need For Early And Accurate Pathogen Detection • Market Trend: Advancements in Digital Technology Enhance Precision and Speed in Disease Detection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Polymerase Chain Reaction Molecular Diagnostics Market?

Polymerase chain reaction (PCR) molecular diagnostics is a laboratory technique used to amplify and analyze specific deoxyribonucleic acid or ribonucleic acid sequences in a sample. Its main purpose is to detect the presence of specific genetic material, enabling the identification of pathogens, genetic disorders, or mutations. It is widely used in medical diagnostics for detecting infectious diseases, genetic disorders, and cancer markers with high sensitivity and accuracy. The main product types of polymerase chain reaction molecular diagnostics are instruments, reagents and consumables, and software. Instruments refer to tools or devices designed to perform specific tasks, measurements, or operations, typically in scientific, medical, or technical fields. These technologies encompass real-time polymerase chain reaction, digital polymerase chain reaction, and conventional polymerase chain reaction for sample types including blood, saliva, tissue, and urine samples. Polymerase chain reaction molecular diagnostics are applied in areas such as infectious disease testing, oncology testing, and others, and are used by several end-users, including hospitals, diagnostic laboratories, and various others.

What Is The Polymerase Chain Reaction Molecular Diagnostics Market Growth Forecast?

The polymerase chain reaction molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $14.65 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing adoption of point-of-care molecular diagnostics, rising investment in personalized medicine, expansion of genomic testing programs, growing demand for decentralized diagnostics, increased integration of digital health platforms. Major trends in the forecast period include increasing use of pcr for infectious disease detection, growing demand for high-sensitivity molecular diagnostics, expansion of pcr-based oncology testing, rising integration of automated diagnostic platforms, enhanced focus on rapid turnaround testing.

Global Polymerase Chain Reaction Molecular Diagnostics Market Segmentation

1) By Product Type: Instrument, Reagents And Consumables, Software 2) By Technology: Real-Time Polymerase Chain Reaction, Digital Polymerase Chain Reaction, Conventional Polymerase Chain Reaction 3) By Sample Type: Blood Samples, Saliva Samples, Tissue Samples, Urine Samples 4) By Application: Infectious Disease Testing, Oncology Testing, Other Applications 5) By End-User: Hospitals, Diagnostic Laboratories, Other End Users Subsegments: 1) By Instrument: Standard Polymerase Chain Reaction Systems, Digital Polymerase Chain Reaction Systems, Real-Time Polymerase Chain Reaction Systems 2) By Reagents And Consumables: Polymerase Chain Reaction Kits, Polymerase Chain Reaction Enzymes, Polymerase Chain Reaction Primers and Probes, Polymerase Chain Reaction Master Mix 3) By Software: Polymerase Chain Reaction Analysis Software, Data Management Software

What Is The Driver Of The Polymerase Chain Reaction Molecular Diagnostics Market?

The rising prevalence of infectious diseases is expected to propel the growth of the polymerase chain reaction molecular diagnostics market going forward. Infectious diseases refer to illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly from one person to another. The prevalence of infectious diseases is increasing due to the emergence of antibiotic-resistant pathogens, which are harder to treat and control, leading to prolonged illness, higher healthcare costs, and greater public health risks. Polymerase chain reaction (PCR) molecular diagnostics enhance infectious disease management by providing rapid, accurate detection of pathogens at the genetic level, enabling early diagnosis and targeted treatment. This improves healthcare outcomes by facilitating timely interventions, reducing the spread of infections, and optimizing patient care. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, there were 2,214 new cases of acute hepatitis B reported. Further, there were 1,769 hepatitis B-related deaths reported during 2023. Therefore, the rising prevalence of infectious diseases is driving the growth of the polymerase chain reaction molecular diagnostics industry.

Key Players In The Global Polymerase Chain Reaction Molecular Diagnostics Market

Major companies operating in the polymerase chain reaction molecular diagnostics market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., bioMereieux SA, Sysmex Corporation, Bio Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, Zymo Research Corporation, QIAGEN N.V., Cepheid Inc., Meridian Bioscience Inc., LGC Biosearch Technologies, Analytik Jena AG, Promega Corporation, BGI Genomics Co. Ltd.

Global Polymerase Chain Reaction Molecular Diagnostics Market Trends and Insights

Major companies in the polymerase chain reaction molecular diagnostics market are focusing on developing technologically advanced solutions such as benchtop instruments to enhance testing efficiency and accessibility. Benchtop instruments refer to compact, laboratory-grade devices that are small enough to fit on a workbench or table and are used for scientific, medical, or industrial testing and analysis. For instance, in September 2024, QIAGEN N.V., a Germany-based biotechnology company, launched the QIAcuityDx Digital PCR System for clinical testing in oncology. These system features are fully automated, walk-away processing that integrates partitioning, thermocycling, and imaging into a single instrument, delivering absolute quantification of deoxyribonucleic acid and ribonucleic acid with results in about two hours and minimal hands-on time. The system supports up to five detection channels for multiplexing and continuous nanoplate loading and offers both validated and flexible research modes, making it adaptable for diverse clinical and laboratory needs.

What Are Latest Mergers And Acquisitions In The Polymerase Chain Reaction Molecular Diagnostics Market?

In May 2024, Bruker Corporation, a US-based manufacturer of high-end analytical instruments, acquired ELITechGroup for $930.9 million. With this acquisition, Bruker Corporation aims to strengthen its position in infectious disease diagnostics by expanding its molecular diagnostic capabilities and product portfolio to better serve clinical laboratories and hospitals globally. ELITech Group SAS is an Italy-based in-vitro diagnostics company that specializes in polymerase chain reaction (PCR) molecular diagnostics.

Regional Outlook

North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Polymerase Chain Reaction Molecular Diagnostics Market?

The polymerase chain reaction molecular diagnostics market consists of revenues earned by entities by providing services such as infectious disease testing, genetic disorder screening, pharmacogenomics testing, deoxyribonucleic acid amplification services, and viral load monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The polymerase chain reaction molecular diagnostics market also includes sales of thermal cyclers, electrophoresis systems, assay kits, and reverse transcriptase enzymes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Polymerase Chain Reaction Molecular Diagnostics Market Report 2026?

The polymerase chain reaction molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reaction molecular diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.